http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104211604-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C65-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C51-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C51-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C215-44
filingDate 2014-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104211604-B
titleOfInvention Eutectic of a kind of ambroxol and P-hydroxybenzoic acid and preparation method thereof
abstract The invention belongs to pharmaceutical co-crystals technical field, be specifically related to a kind of novel ambroxol pharmaceutical co-crystals and preparation method thereof. The ambroxol pharmaceutical co-crystals space group that the present invention prepares is monoclinic system, two ambroxol molecules, and two P-hydroxybenzoic acid and a hydrone are by forming the elementary cell of ambroxol pharmaceutical co-crystals together with Hydrogenbond. The solvent that pharmaceutical co-crystals preparation process of the present invention is selected is the mixed solvent of first alcohol and water, and employing method is solvent room temperature volatility process, because the boiling point of selected solvent is relatively low, therefore crystal will be separated out in the process of solvent evaporates. Pharmaceutical co-crystals prepared by the present invention is outside the speciality such as the eliminating of the inner thick secretions of promotion respiratory tract and the delay of minimizing mucus of having inherited ambroxol, and stability is significantly improved.
priorityDate 2014-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3536713-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3950393-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493733
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2132
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID243
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22242641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448981304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484158
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414855407
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457623688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452125866
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID108013
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419482754

Total number of triples: 38.